Drug Trial Radar · NCT07424287
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
Last checked: Nov 19, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
236
Planned (sponsor's estimate)
Start
Jul 13, 2026
Primary completion
Jun 2030
Study completion Jun 2030
Sponsor
- Lead sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, open-label phase III study to determine the efficacy and safety of intravesical SHR-1501 combined with Bacillus Calmette Guerin (BCG) versus investigator-selected chemotherapy in patients with BCG-unresponsive papillary-only non-muscle-invasive bladder cancer (NMIBC).
Conditions
- NMIBC
Interventions
SHR-1501 for InjectionDrug
SHR-1501 for injection.
BCG for InjectionDrug
Bacillus calmette guerin (BCG) for injection.
Epirubicin Hydrochloride for InjectionDrug
Epirubicin hydrochloride for injection.
Pirarubicin Hydrochloride for InjectionDrug
Pirarubicin hydrochloride for injection.
Gemcitabine Hydrochloride for InjectionDrug
Gemcitabine hydrochloride for injection.
Hydroxycamptothecin for InjectionDrug
Hydroxycamptothecin for injection.
Mitomycin for InjectionDrug
Mitomycin for injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-Free Survival (DFS) assessed by Blinded Independent Central Review (BICR)Time frame: Up to approximately 5 years.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Peking University First Hospital
Beijing, Beijing Municipality, China · Recruiting
Renji Hospital Affiliated to Shanghai Jiao Tong University School
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.